Article Text
Treatment
Primary prevention with pravastatin for 5 years continued to prevent coronary events in the next 10 years
Statistics from Altmetric.com
Footnotes
Source of funding: Chief Scientist Office of the Scottish Executive Health Department, Bristol-Myers Squibb, and Sankyo.